| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 8.76B | 10.36B | 11.65B | 9.91B | 9.10B |
| Gross Profit | 3.05B | 3.30B | 2.93B | 1.80B | 2.35B |
| EBITDA | 3.78B | 3.98B | 3.75B | 2.50B | 3.81B |
| Net Income | 1.51B | 1.46B | 1.19B | 624.23M | 1.87B |
Balance Sheet | |||||
| Total Assets | 63.71B | 61.07B | 57.66B | 40.26B | 40.73B |
| Cash, Cash Equivalents and Short-Term Investments | 4.39B | 2.95B | 1.98B | 2.55B | 3.84B |
| Total Debt | 38.48B | 36.49B | 34.58B | 19.35B | 20.04B |
| Total Liabilities | 42.46B | 41.57B | 40.99B | 21.54B | 22.28B |
| Stockholders Equity | 20.15B | 18.40B | 15.67B | 17.81B | 17.36B |
Cash Flow | |||||
| Free Cash Flow | 879.62M | 652.40M | -1.51B | -2.06B | -2.05B |
| Operating Cash Flow | 3.32B | 3.70B | 3.23B | 2.01B | 1.58B |
| Investing Cash Flow | -2.41B | -3.20B | -1.98B | -3.48B | -1.56B |
| Financing Cash Flow | 520.97M | 464.23M | -1.86B | 190.61M | 641.85M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | HK$6.73B | 13.69 | 5.90% | 5.26% | 7.04% | 7.64% | |
69 Neutral | HK$28.56B | 10.82 | 15.46% | 5.08% | 5.50% | 11.50% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | HK$3.36B | 5.67 | 10.43% | 5.25% | 3.78% | -17.34% | |
61 Neutral | HK$25.37B | -12.81 | 5.00% | 3.72% | 7.13% | -52.33% | |
58 Neutral | HK$17.50B | 9.34 | 6.54% | 6.96% | -22.68% | 9.22% | |
52 Neutral | HK$18.83B | 14.25 | 8.39% | 5.82% | -20.02% | 42.97% |